The aberrant activation of these TFs, such as LMO2/LYL1, HOXA, TLX1/3, NKX2 and TAL1, contributes to the pathogenesis of T-ALL [17,18,19]. The gene discussed is LMO2; the disease is acute lymphoblastic leukemia.